What is MaxCyte's total cost of revenue?

MaxCyte (MXCT) reported total cost of revenue of $1.57M in Q1 2026.

How has MaxCyte's total cost of revenue changed year-over-year?

MaxCyte's total cost of revenue increased by 4.8% year-over-year, from $1.5M to $1.57M.

What is the long-term trend for MaxCyte's total cost of revenue?

Over 4 years (2021 to 2025), MaxCyte's total cost of revenue has grown at a 14.3% compound annual growth rate (CAGR), from $3.65M to $6.22M.

What does total cost of revenue mean?

The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

MaxCyte MXCT Total Cost of Revenue

Total Cost of Revenue at other companies

Bio-Rad LaboratoriesBIO

$282.7M+1.2%

Ginkgo BioworksDNA

$3.1M-24.3%

Rapid Micro BiosystemsRPID

$7.63M+12.2%

PDE

Pro-Dex, Inc.PDEX

$13.82M+18.9%

RepligenRGEN

$85.97M+10.5%

TEC

Bio-TechneTECH

$103.13M+1.5%

Segments

By segment

See full

Cell Engineering Technology$1.57M+4.8%

Other financials

Income statement

See full

Revenue$9.7M-7.1%

Gross profit$8.1M-9.1%

Operating income-$6.2M+49.7%

Net income-$4.8M+53.7%

EPS (diluted)-$0.04+60.0%

Balance sheet

See full

Cash & equivalents$14.6M-37.8%

Total debt$17.5M-7.1%

Total equity$167.9M-15.8%

Total assets$194.5M-15.4%

Cash flow

See full

Operating cash flow-$8.2M+43.3%

CapEx$72.0K-89.0%

Free cash flow-$8.2M+45.3%

Valuation

See full

Market cap$130.15M-46.8%

Enterprise value$133.08M-46.3%

P/S4×-2.8×

Profitability

See full

Gross margin80.5%-0.4pp

Operating margin-141.8%+6.4pp

Net margin-121.2%+12.3pp

FCF margin-90.9%+3.7pp

Returns & leverage

See full

Return on equity-21.3%+2.0pp

Debt / equity0.1×0.0×

Current ratio12×-0.2×

Where this comes from

Reported directly by MaxCyte in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: MaxCyte’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about MaxCyte's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is MaxCyte's total cost of revenue?: MaxCyte (MXCT) reported total cost of revenue of $1.57M in Q1 2026.
How has MaxCyte's total cost of revenue changed year-over-year?: MaxCyte's total cost of revenue increased by 4.8% year-over-year, from $1.5M to $1.57M.
What is the long-term trend for MaxCyte's total cost of revenue?: Over 4 years (2021 to 2025), MaxCyte's total cost of revenue has grown at a 14.3% compound annual growth rate (CAGR), from $3.65M to $6.22M.
What does total cost of revenue mean?: The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.